Multiple myeloma
What is multiple myeloma?
Multiple myeloma is a cancer that starts in plasma cells. It is the most common type of plasma cell cancer.
Risk factors for multiple myeloma
Risk factors for multiple myeloma include a history of monoclonal gammopathy of undetermined significance (MGUS). Learn about multiple myeloma risk.
Symptoms of multiple myeloma
Common signs and symptoms of multiple myeloma include bone pain or weakness, fatigue and frequent infections.
Diagnosis of multiple myeloma
Multiple myeloma can be diagnosed or ruled out by tests such as blood and urine tests, biopsy and imaging tests.
Stages of multiple myeloma
The stage of multiple myeloma describes how much cancer is in the body.
Spread of multiple myeloma
Multiple myeloma is often widespread by the time it is diagnosed and affects multiple bones. Learn more about the progression of multiple myeloma.
Prognosis and survival for multiple myeloma
Prognosis estimates the outcome for multiple myeloma. It depends on many factors including stage, age, blood test results and chromosome changes.
Treatments for multiple myeloma
Multiple myeloma can be treated with watchful waiting, targeted therapy, chemotherapy, stem cell transplant, immunotherapy and supportive therapy. It can sometimes be treated with radiation therapy.
Supportive care for multiple myeloma
Supportive care helps people with physical and emotional aspects of multiple myeloma. Learn more about coping with long-term side effects of multiple myeloma.
Multiple myeloma statistics
Cancer statistics tell us how many people in Canada are diagnosed with and die from multiple myeloma in a certain time frame.
Your trusted source for accurate cancer information
With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.
We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.
If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.